Camille L Bedrosian
CIK 1326969 · View on SEC EDGAR ↗
Insider
First SEC filing: June 22, 2026 · Latest: June 22, 2026
On this page
Insider at
Insider transactions
0 buys (P)
3 sells (S)
Net:
$-364,153
+ 60 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
60 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | AMLX | S | 6,461 | $14.58 | $94,201 | 169,295 Direct | -3.68% | Disposed | 178.6% (price as of 2026-08-21) |
| Dec. 1, 2025 | AMLX | S | 6,580 | $14.35 | $94,423 | 175,756 Direct | -3.61% | Disposed | 183.1% (price as of 2026-08-21) |
| Sept. 30, 2025 | AMLX | S | 12,039 | $14.58 | $175,529 | 182,336 Direct | -6.19% | Disposed | 178.6% (price as of 2026-08-21) |
| March 31, 2025 | AMLX | S | 12,425 | $3.47 | $43,115 | 194,375 Direct | -6.01% | Disposed | 1070.7% (price as of 2026-08-21) |
| Dec. 2, 2024 | AMLX | S | 5,421 | $5.54 | $30,032 | 138,380 Direct | -3.77% | Disposed | 633.3% (price as of 2026-08-21) |
| Sept. 30, 2024 | AMLX | S | 11,442 | $3.20 | $36,614 | 143,801 Direct | -7.37% | Disposed | 1169.5% (price as of 2026-08-21) |
| March 1, 2023 | RARE | S | 3,881 | $45.25 | $175,615 | 46,720 Direct | -7.67% | Disposed | -42.3% (price as of 2026-08-21) |
| March 1, 2022 | RARE | S | 2,821 | $66.62 | $187,935 | 33,938 Direct | -7.67% | Disposed | -60.8% (price as of 2026-08-21) |
| Jan. 30, 2022 | RARE | S | 1,657 | $66.30 | $109,859 | 36,759 Direct | -4.31% | Disposed | -60.6% (price as of 2026-08-21) |
| Oct. 14, 2021 | RARE | S | 359 | $81.14 | $29,129 | 38,416 Direct | -0.93% | Disposed | -67.8% (price as of 2026-08-21) |
| Sept. 2, 2021 | RARE | S 10b5-1 | 2,500 | $100.18 | $250,450 | 38,775 Direct | -6.06% | Disposed | -73.9% (price as of 2026-08-21) |
| Sept. 1, 2021 | RARE | S 10b5-1 | 2,500 | $100.03 | $250,075 | 38,775 Direct | -6.06% | Disposed | -73.9% (price as of 2026-08-21) |
| May 6, 2021 | RARE | S | 364 | $113.67 | $41,376 | 38,775 Direct | -0.93% | Disposed | -77.0% (price as of 2026-08-21) |
| April 15, 2021 | RARE | S 10b5-1 | 5,000 | $109.09 | $545,450 | 39,139 Direct | -11.33% | Disposed | -76.1% (price as of 2026-08-21) |
| March 1, 2021 | RARE | S | 4,543 | $138.18 | $627,752 | 39,139 Direct | -10.40% | Disposed | -81.1% (price as of 2026-08-21) |
| Jan. 30, 2021 | RARE | S | 2,243 | $140.36 | $314,827 | 33,546 Direct | -6.27% | Disposed | -81.4% (price as of 2026-08-21) |
| Jan. 15, 2021 | RARE | S 10b5-1 | 25,000 | $139.18 | $3,479,500 | 35,789 Direct | -41.13% | Disposed | -81.2% (price as of 2026-08-21) |
| Oct. 14, 2020 | RARE | S | 262 | $88.00 | $23,056 | 35,789 Direct | -0.73% | Disposed | -70.3% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 18, 2026 | CRNX | Stock Option (Right to Buy) | Common Stock (9,730) | $35.87 | June 18, 2036 | 9,730 | Acquired |
| March 5, 2026 | AMLX | Stock Option (Right to Buy) | Common Stock (143,985) | $14.10 | March 5, 2036 | 143,985 | Acquired |
| June 24, 2025 | RYTM | Restricted Stock Units | Common Stock (4,712) | — | — | 4,712 | Acquired |
| June 24, 2025 | RYTM | Stock Option (right to buy) | Common Stock (7,037) | $63.66 | June 23, 2035 | 7,037 | Acquired |
| June 18, 2025 | RYTM | Restricted Stock Units | Common Stock (4,000) | — | — | 4,000 | Disposed |
| June 11, 2025 | CRNX | Stock Option (right to buy) | Common Stock (10,350) | $32.33 | June 11, 2035 | 10,350 | Acquired |
| March 6, 2025 | AMLX | Stock Option (Right to Buy) | Common Stock (102,630) | $3.61 | March 5, 2035 | 102,630 | Acquired |
| June 21, 2024 | RYTM | Restricted Stock Units | Common Stock (3,000) | — | — | 3,000 | Disposed |
| June 18, 2024 | RYTM | Restricted Stock Units | Common Stock (4,000) | — | — | 4,000 | Acquired |
| June 18, 2024 | RYTM | Stock Option (right to buy) | Common Stock (14,000) | $41.39 | June 17, 2034 | 14,000 | Acquired |
| June 7, 2024 | CRNX | Stock Option (right to buy) | Common Stock (12,500) | $44.71 | June 7, 2034 | 12,500 | Acquired |
| April 16, 2024 | AMLX | Stock Option (Right to Buy) | Common Stock (120,000) | $2.01 | April 15, 2034 | 120,000 | Acquired |
| Nov. 27, 2023 | AMLX | Stock Option (Right to Buy) | Common Stock (162,500) | $12.93 | Nov. 26, 2033 | 162,500 | Acquired |
| June 21, 2023 | RYTM | Restricted Stock Units | Common Stock (3,000) | — | — | 3,000 | Acquired |
| June 21, 2023 | RYTM | Stock Option (right to buy) | Common Stock (14,000) | $18.47 | June 20, 2033 | 14,000 | Acquired |
| June 16, 2023 | CRNX | Stock Option (right to buy) | Common Stock (17,500) | $20.32 | June 15, 2033 | 17,500 | Acquired |
| June 17, 2022 | CRNX | Stock Option (right to buy) | Common Stock (17,500) | $18.29 | June 16, 2032 | 17,500 | Acquired |
| June 8, 2022 | RYTM | Stock Option (right to buy) | Common Stock (20,000) | $4.15 | June 7, 2032 | 20,000 | Acquired |
| March 1, 2022 | RARE | Stock Option (Right to Buy) | Common Stock (24,900) | $67.37 | March 1, 2032 | 24,900 | Acquired |
| Sept. 2, 2021 | RARE | Stock Option (Right to Buy) | Common Stock (2,500) | $55.00 | Jan. 30, 2028 | 2,500 | Disposed |
| Sept. 1, 2021 | RARE | Stock Option (Right to Buy) | Common Stock (2,500) | $55.00 | Jan. 30, 2028 | 2,500 | Disposed |
| June 22, 2021 | CRNX | Stock Option (right to buy) | Common Stock (17,500) | $20.23 | June 21, 2031 | 17,500 | Acquired |
| June 9, 2021 | RYTM | Stock Option (right to buy) | Common Stock (15,000) | $18.99 | June 8, 2031 | 15,000 | Acquired |
| April 15, 2021 | RARE | Stock Option | Common Stock (5,000) | $55.00 | Jan. 30, 2028 | 5,000 | Disposed |
| March 1, 2021 | RARE | Stock Option (Right o Buy) | Common Stock (11,000) | $142.47 | March 1, 2031 | 11,000 | Acquired |
| Jan. 15, 2021 | RARE | Stock Option (Right to Buy) | Common Stock (25,000) | $55.00 | Jan. 30, 2028 | 25,000 | Disposed |
| Dec. 9, 2020 | RYTM | Stock Option (Right to Buy) | Common Stock (37,000) | $28.27 | Dec. 8, 2030 | 37,000 | Acquired |
| Sept. 1, 2020 | CRNX | Stock Option (right to buy) | Common Stock (25,000) | $16.08 | Aug. 31, 2030 | 25,000 | Acquired |
| March 1, 2020 | RARE | Stock Option (Right to Buy) | Common Stock (21,000) | $56.08 | March 1, 2030 | 21,000 | Acquired |
| March 1, 2019 | RARE | Stock Option (Right to Buy) | Common Stock (21,500) | $67.55 | March 1, 2029 | 21,500 | Acquired |
| Jan. 30, 2018 | RARE | Employee Stock Option (Right to Buy) | Common Stock (88,000) | $55.00 | Jan. 30, 2028 | 88,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
RARE
EVP| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $596,000 | — | $2,007,768 | $892,550 | $246,750 | — | $12,200 | $3,755,268 |
| 2021 | $567,123 | — | $1,653,212 | $866,427 | $249,260 | — | $8,700 | $3,344,722 |
| 2020 | $546,686 | — | $695,392 | $674,871 | $297,731 | — | — | $2,214,680 |
AMLX
M.D. (5)Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $575,000 | — | — | — | $275,569 | — | $157,237 | $1,567,674 |
| 2023 | $56,763 | $173,000 | — | — | — | — | $2,838 | $2,372,859 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.